Results

Total Results: 1,569 records

Showing results for "discussed".

  1. SRDR-Charter-140305 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/data-repository-reviews-charter-140305.pdf
    June 01, 2012 - − The list of potential board members will be reviewed and each potential board member will be discussed
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-framework_research.pdf
    March 01, 2012 - As discussed above, the descriptors of the study design considerations should be brief. … As discussed previously, the authors of the FRN report should encourage creativity and emphasize that … are derived from the Alberta report, and are commonly used in association with the study designs discussed
  3. effectivehealthcare.ahrq.gov/sites/default/files/module-iii-points-of-engagement-in-the-ehc-program.pdf
    May 29, 2025 - Module III: Points of Engagement in the EHC Program …
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-disposition-comments.pdf
    May 14, 2025 - We have discussed both MCSTs selected for the Vanguard trial in Table 1 and have added additional information … We believe that we have appropriately and thoroughly discussed the strengths and limitations of each
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_disposition-comments.pdf
    September 15, 2014 - For some specific studies some key aspects are not well- described or are not discussed in the text … description of this study to show this unusual finding. 60 Peer Reviewer 2 Results Page 163, As discussed … the original 2009 report. 117 Public comment: John Aloia Line 337 Line 337: The cost should be discussed
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/disposition-of-comments-cer-192-anxiety-in-children.pdf
    August 31, 2017 - As discussed in later sections of our review, the subgroup analyses were quite weak and did not appear … As discussed previously, there is a serious mismatch between the ambitious aims of the report in the
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-211-rheumatoid-arthritis-disposition-comments.pdf
    December 20, 2018 - Selected PROs were discussed in the text, and the remainder are found in the tables. … Comment Response Peer Reviewer #1 Discussion Limitations: Some weakness of the NWMA were well discussed … P88: Patient discontinuation rates varied significantly across the RCTs and observational studies discussed … Reasons for this variation and how it may impact on the applicability of the results should be discussed … Section Comment Response missing even more trials as there might have been cases where authors had discussed
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
    September 01, 2011 - specifically in the field of transcranial magnetic stimulation (TMS), is ongoing and the publications discussed
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-216-telehealth-disposition-comments.pdf
    April 24, 2019 - CER 216 Disposition of Comments Report: Telehealth for Acute and Chronic Care Consultations Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Telehealth for Acute and Chronic Care Consultations Draft review available for public comment from May 29, 2018 to June 26, 2018. Res…
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antibiotics-respiratory-infection_disposition-comments.pdf
    January 27, 2016 - So the heavily contextual nature of this approach should be similarly discussed in the strengths and … not be grouped with others because of the variability of component combinations and had to be discussed … peer review consensus about the challenges of measuring resistance and appropriate prescribing (discussed … Perhaps this should be discussed, with a set of options.
  11. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
    September 01, 2022 - Key Considerations for Including or Excluding NRSIs Section 3 discussed the strengths and limitations … As discussed in Section 1, RCTs, particularly explanatory RCTs, generally are designed to determine … As discussed in Section 7, confounding is an important threat to validity of NRSIs. … Interpreting Results From NRSIs As discussed in Section 7, when interpreting results of NRSIs, it is … Where inconsistencies are detected, their likely sources should be explored and discussed.
  12. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
    September 01, 2022 - Key Considerations for Including or Excluding NRSIs Section 3 discussed the strengths and limitations … As discussed in Section 1, RCTs, particularly explanatory RCTs, generally are designed to determine … As discussed in Section 7, confounding is an important threat to validity of NRSIs. … Interpreting Results From NRSIs As discussed in Section 7, when interpreting results of NRSIs, it is … Where inconsistencies are detected, their likely sources should be explored and discussed.
  13. Project Name: (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_disposition-comments.pdf
    October 25, 2011 - effects model. 1 P15 ln 40 Exec summary KQ1 – describe Type III and IV monitors before these are discussed … The key questions are appropriate and well formulated We have discussed this with our Task Order Officer … the full report (page 15, near bottom, Chapter 4 page 131): Of note, where interventions are not discussed … Numerous theoretical and research issues are also discussed that help the reader to carefully interpret … Limitations of the included studies are discussed in a thoughtful and objective manner.
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-269-respectful-maternity-care-summary.pdf
    January 01, 2024 - Methods are discussed in detail in the full report and in Appendix A.
  15. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/registry-of-patient-registries_research.pdf
    April 15, 2019 - Some reports discussed the potential for using data captured in EHRs during routine clinical care to … While use of standardized outcome measures is important for the reasons discussed 19 earlier in … These are discussed further in the following section. … These issues, together with recommended best practices, are discussed further below. … The review of existing initiatives identified three issues related to metadata, as discussed in the
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_disposition-comments.pdf
    January 07, 2013 - Disposition of Comments Report for Assessment and Management of Chronic Cough Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=1371 Published Online: January 7, 2013 Comparative Effectiveness Research Review Disposition of Comments Repor…
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-212-urinary-incontinence-disposition-comments.pdf
    August 08, 2018 - Furthermore, assumptions and limitations need to be discussed for the specific methods implemented … Thank you Methods Peer Reviewer #3 I prefer to see definitions of 'meaningful clinical differences' discussed … For instance, in neither the exec summary or the report itself is this issue discussed. … We have, however, more clearly discussed the evidence pertinent to the specific populations, as subanalyses … Limiting the review to non surgical treatments is a fair limitation of scope, as most of the techniques discussed
  18. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/healthcare-algorithms-agenda-for-March-23.pdf
    May 29, 2025 - Agenda: Impact of Healthcare Algorithms on Racial and Ethnic Disparities 1 IMPACT OF HEALTHCARE ALGORITHMS ON RACIAL AND ETHNIC DISPARITIES IN HEALTH AND HEALTHCARE AGENDA March 2–3, 2023 National Institutes of Health (NIH) Natcher Conference Center 45 Center Drive, Building 45, Bethesda, MD 20892 …
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/continuous-outcomes-quantitative-synthesis_methods.pdf
    March 01, 2011 - SMD and RoM are discussed in detail in subsequent sections. … The issues of missing individuals and missing study-level data will be discussed briefly. … The difference in handling skewed data was discussed as one of the reasons that the two analyses … For example, Ma et al. 37 discussed a nonparametric method that utilizes U-statistic theory. … Furukawa et al. also discussed how imputing SD applies to SMD, and more information on imputing SD
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/data-repository-reviews_white-paper.pdf
    September 01, 2012 - including the specifics of the functioning, role and responsibilities of the governing body would be discussed … developed in partnership with the governing body. 8 Conclusion Herein, we have discussed

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: